Jeffrey R. Stewart, an officer of AbbVie Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 40,619 shares of AbbVie common stock acquired through a stock option exercise on the same date.
Hadron Energy, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 9, 2026, reporting net income of $25,502 thousand for the nine months ended September 30, 2026, compared to a net loss of $31,198 thousand …
Primis Financial Corp. filed its Form 10-Q with the SEC on November 9, 2026, reporting unaudited financial results for the quarterly period ended September 30, 2026, under NASDAQ:FRST.
Motorcar Parts of America, Inc. filed a Form 10-Q with the SEC on November 9, 2026, reporting unaudited financial results for the quarterly period ended September 30, 2026, and the six-month period then ended.
Eagle Financial Services, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting third-quarter net income of $4.75 million and total assets of $1.87 billion.
Telos Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, reporting a return to profitability in both the third quarter and the nine-month period compared with the same periods in …
Oxbridge Re Holdings Limited filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting total assets of $19,965 thousand and a net loss attributable to ordinary shareholders of $223 thousand for the nine months …
Rave Restaurant Group, Inc. filed its Form 10-Q for the quarterly period ended September 27, 2026, reporting first-quarter fiscal 2027 results with revenues of $3,322 thousand and net income of $665 thousand.
BioForce Nanosciences Holdings, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing a net loss of $341,680 for the third quarter and reporting a significant improvement in total stockholders' equity compared to year-end 2025.
Neurogene Inc. filed a Form 10-Q with the SEC on November 9, 2026, reporting condensed consolidated financial results for the quarterly period ended September 30, 2026.